Science Explorer Interactive view Map
Company · Singapore · Singapore

Novartis (Singapore)

novartis.comROR OpenAlex
World rank, all time
#9,755
of 42,892
Rank in Singapore
#44
of 126
Research works
154
▼ 75% vs 2013–17
Citations
11k
72.4 per fractional work
Top-10% rate
12.9%
record average 16.5%
Open access
51%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.31× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 2.56× its world share, 0 worksImmunology and Micro…Chemistry: 0.80× its world share, 0 worksChemistryComputer Science: 1.56× its world share, 1 worksComputer ScienceEngineering: 1.06× its world share, 2 worksEngineeringMaterials Science: 0.85× its world share, 0 worksMaterials ScienceMedicine: 2.35× its world share, 5 worksMedicineBusiness, Management and Accounting: 0.90× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.80× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 2.6×. Every wedge is a field page.

Which keywords describe research at Novartis (Singapore)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Vaccine Development, Vector Control, Immune Response, Arboviral Diseases, Zika Virus, Vaccine and Treatment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology63▲ 10×33 topics
  2. Vaccine Development35▲ 74×5 topics
  3. Vector Control27▲ 149×4 topics
  4. Immune Response22▲ 23×13 topics
  5. Arboviral Diseases22▲ 229×1 topic
  6. Zika Virus22▲ 229×1 topic
  7. Vaccine20▲ 33×9 topics
  8. Treatment17▲ 8.5×13 topics
  9. Genetic Diversity16▲ 21×2 topics
  10. Diagnosis16▲ 10×11 topics
  11. Drug Resistance14▲ 29×4 topics
  12. Antiretroviral Therapy14▲ 38×5 topics
  13. Genome Sequence13▲ 80×2 topics
  14. Global Burden12▲ 15×4 topics
  15. Artemisinin Resistance12▲ 204×1 topic
  16. Insecticide Resistance12▲ 80×2 topics
  17. Plasmodium falciparum12▲ 204×1 topic
  18. Pathogenesis10▲ 12×9 topics
  19. HIV10▲ 53×2 topics
  20. Public Health10▲ 4.6×6 topics
  21. Mycobacterium tuberculosis9▲ 86×1 topic
  22. Tuberculosis9▲ 104×1 topic
  23. Antibodies9▲ 63×2 topics
  24. AIDS8▲ 103×1 topic
  25. Immune Activation8▲ 59×1 topic
  26. Viral Hemorrhagic Fevers7▲ 102×1 topic
  27. Zoonotic Infections7▲ 79×1 topic
  28. Machine Learning7▲ 2.2×10 topics
  29. Medicinal Chemistry7▲ 12×4 topics
  30. Pharmacokinetics6▲ 15×3 topics
  31. Molecular Docking6▲ 26×3 topics
  32. Antibiotic Resistance5▲ 8.7×4 topics
  33. Synthesis5▲ 5.8×11 topics
  34. Drug Target Identification5▲ 46×1 topic
  35. Virtual Screening5▲ 46×1 topic
  36. Genomic Studies5▲ 36×2 topics
  37. Genetic Variants4▲ 12×3 topics
  38. Host-Pathogen Interactions4▲ 24×2 topics
  39. Mycobacterium avium4▲ 53×1 topic
  40. Nontuberculous Mycobacteria4▲ 53×1 topic

Which research topics does Novartis (Singapore) publish most on?

By volume in 2022–2025: Lipoproteins and Cardiovascular Health, Technology and Data Analysis, CAR-T cell therapy research and Chronic Myeloid Leukemia Treatments.

Lipoproteins and Cardiov…1Lipoproteins and Cardiovascular Health: 1 fractional worksTechnology and Data Anal…0Technology and Data Analysis: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksChronic Myeloid Leukemia…0Chronic Myeloid Leukemia Treatments: 0 fractional worksPluripotent Stem Cells Research: 0 fractional worksHair Growth and Disorders: 0 fractional worksMesenchymal stem cell re…0Mesenchymal stem cell research: 0 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksHealthcare Systems and R…0Healthcare Systems and Reforms: 0 fractional works
SurgeryInformation SystemsOncologyHematology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lipoproteins and Cardiovascular Health Surgery 1 works
  2. 2 Technology and Data Analysis Information Systems 0 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 0 works
  5. 5 Pluripotent Stem Cells Research Molecular Biology 0 works
  6. 6 Hair Growth and Disorders Urology 0 works
  7. 7 Mesenchymal stem cell research Genetics 0 works
  8. 8 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  9. 9 Cancer Genomics and Diagnostics Cancer Research 0 works
  10. 10 Healthcare Systems and Reforms Finance 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.8%not open49.2%

World: 28% of research is openly available.

with international co-authors51.0%domestic only49.0%

World: 19% is written across borders.

How has Novartis (Singapore)'s research output changed?

Output in 2018–2022 was 75% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Singapore

All research institutions in Singapore

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.